Day One Biopharmaceuticals CEO Jeremy Bender's 2021 pay jumps 618% to $20M
Day One Biopharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Day One Biopharmaceuticals reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, three executives at Day One Biopharmaceuticals received on average a compensation package of $10M, a 532% increase compared to previous year.
Average pay of disclosed executives at Day One Biopharmaceuticals
Jeremy Bender, Chief Executive Officer, received $20M in total, which increased by 618% compared to 2020. 70% of Bender's compensation, or $14M, was in option awards. Bender also received $314K in non-equity incentive plan, $523K in salary, as well as $5.2M in stock awards.
Charles York II, Chief Financial Officer, received a compensation package of $7.9M. 59% of the compensation package, or $4.7M, was in option awards.
Samuel Blackman, Chief Medical Officer, earned $2.9M in 2021, a 515% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2022.